Hints and tips:
...AstraZeneca has settled disputes on drugs Nexium and Prilosec for a combined total of $425mn, “effectively” resolving product liability claims in some US states....
...AstraZeneca has settled disputes on stomach drugs Nexium and Prilosec for a combined total of $425mn, “effectively” resolving product liability claims in some US states....
...It has long been overtaken in sales by more recent products such as Prilosec....
...AstraZeneca had the option this summer to exercise an option to buy out of the marketing partnership with Merck, which takes a share of US sales of its products Prilosec and Nexium for heartburn and Vimovo...
...Teva markets a generic version of Prilosec and under the terms of Thursday’s agreement, it will make a one-off, undisclosed payment to AstraZeneca to compensate for past sales of generic Prilosec....
...- AstraZeneca reaches agreement with Teva over Nexium and Prilosec patents – statement. - Autonomy signs significant license agreement with BAE Systems – statement....
...Mr Lafley said P&G would focus on developing its consumer healthcare business, including Prilosec, as part of efforts to target the ageing population....
...The Indian company will also win the US distribution rights to two other AstraZeneca drugs, Prilosec and Plendil, and begin manufacturing the active pharmaceutical ingredient for Nexium in the US under contract...
...P&G has also pushed though price increases, including a 10 per cent rise on heartburn drug Prilosec in September....
...As a result, the standard treatment now combines a short course of antibiotics with a medicine such as AstraZeneca's Prilosec that reduces acid secretion....
...Sales were led by a 12 per cent rise at P&G’s healthcare business, which sells Prilosec for heartburn. Net earnings at the unit rose by 42 per cent to $182m....
International Edition